Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition
Abstract Hepatocellular carcinoma (HCC) is a malignancy with high morbidity and mortality but lacks effective treatments thus far.Although the emergence of immune checkpoint inhibitors in recent years has shed light on the treatment of HCC, a Wooden Shape Sorting considerable number of patients are still unable to achieve durable and ideal clinical